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Background: Scapula alata (SA) is a known complication of breast surgery associated with palsy of the serratus
anterior, but it is seldom mentioned. We evaluated the risk factors associated with SA and the relationship of SA
with ipsilateral shoulder/arm morbidity in a series of patients enrolled in a trial of post-surgery radiotherapy (RT).
Methods: The trial randomized women with completely resected stage I-II breast cancer to short-course
image-guided RT, versus conventional RT. SA, arm volume and shoulder-arm mobility were measured prior to RT
and at one to three months post-RT. Shoulder/arm morbidities were computed as a post-RT percentage change
relative to pre-RT measurements.
Results: Of 119 evaluable patients, 13 (= 10.9%) had pre-RT SA. Age younger than 50 years old, a body mass index less
than 25 kg/m2, and axillary lymph node dissection were significant risk factors, with odds ratios of 4.8 (P= 0.009), 6.1
(P=0.016), and 6.1 (P=0.005), respectively. Randomization group was not significant. At one to three months’
post-RT, mean arm volume increased by 4.1% (P= 0.036) and abduction decreased by 8.6% (P= 0.046) among SA
patients, but not among non-SA patients. SA resolved in eight, persisted in five, and appeared in one patient.
Conclusion: The relationship of SA with lower body mass index suggests that SA might have been underestimated in
overweight patients. Despite apparent resolution of SA in most patients, pre-RT SA portended an increased risk of
shoulder/arm morbidity. We argue that SA warrants further investigation. Incidentally, the observation of SA occurring
after RT in one patient represents the second case of post-RT SA reported in the literature.
Keywords: Breast cancer, Surgery, Radiation treatment, Complications, Winged scapula, Scapular winging, Long
thoracic nerve, Multiple outcomes, Shoulder/arm morbidity, LymphedemaBackground
Scapula alata (SA), also called scapular winging, winged
scapula or alar scapula, is a condition in which the
medial border and angulus inferior of the scapula
protrudes prominently from the thorax [1]. It can arise
from numerous pathologic processes, which lead to a
deficiency of the muscles that play a role in pulling the
scapula towards the thoracic wall -serratus anterior,* Correspondence: anhxang@gmail.com
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distribution, and reproduction in any mediumtrapezius (pars descendens), and rhomboids - such as by
injury of the long thoracic nerve (the most common
cause), the spinal accessory nerve and the dorsal scapular
nerve respectively [2]. The condition can be distressful
and debilitating [3]. Depending on the underlying causes,
the compensatory muscular activity required to improve
shoulder stability can be associated with secondary pain
and spasm due to muscle imbalances or tendinitis
around the shoulder joint [4].
SA associated with serratus anterior palsy is a known
complication of breast and axillary surgery. In 1825,
Velpeau cautioned that any axillary operation should be
carefully carried out to avoid damaging the long
thoracic nerve. He described that symptoms of damageentral Ltd. This is an Open Access article distributed under the terms of the
creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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upwards and the inability of the scapula to come into
close apposition with the thorax [5] (page 303). Yet des-
pite the long-known history, SA has seldom been inves-
tigated in breast cancer research, in contrast with other
domains, such as sports medicine. There are consider-
ably large variations in the reported incidence of SA
after breast surgery, ranging from 0% to 74.7% [6-10],
without clear explanation of the variability.
Our institution conducted, from 2007 to 2011, the
TomoBreast randomized clinical trial which compared
post-operative short-course image-guided radiotherapy
(IGRT) with conventional radiotherapy (conventional
RT) for early breast cancer. SA was not a specified end-
point of the trial. Nevertheless, it was systematically
assessed in patients enrolled in the trial. We believe that
an analysis of the trial’s data might provide new insight
into the clinical significance of SA. In the present study,
our aims are to evaluate the incidence of SA among the
patients who participated in the trial, to identify patients’
characteristics associated with SA, and to evaluate the
relationship of SA with physical measurements of arm
volume and shoulder-arm mobility.
Methods
Selection of patients
The study population consisted of women who partici-
pated in the TomoBreast clinical trial (NCT00459628,
ISRCTN21164902) approved by the University Hospital
of Brussels’ ethics board. The trial recruited women aged
18 years or older, presenting with a primary breast car-
cinoma completely removed by mastectomy or by
breast-conserving surgery, pathological stage pT1-
3N0M0 or pT1-2N1M0 with pathological nodal status
assessed by axillary lymph node dissection (ALND) or by
sentinel nodes biopsy (SNB), who were to receive post-
surgery radiotherapy. Women who gave written informed
consent were allocated to either a control group or to an
experimental group by computer randomization. In
order to reduce the risk of imbalance due to the small
size of the trial, randomization used Efron’s biased coin
design: instead of a fixed 1/2 probability, the probability
of a new patient being allocated to the control or to the
experimental group was assigned as 1/3, as 1/2, or as 2/
3, depending on how many preceding patients, stratified
by nodal status, type of surgery, and chemotherapy se-
quence, had been previously allocated in one or the other
group [11]. In the control group, a dose of 50 Gy was
delivered in 25 fractions over five weeks to the chest wall
using tangential photon fields, and in cases of pN1 sta-
tus, to the supraclavicular, infraclavicular and axillary
nodes using an anterior field matched to the tangential
fields. Breast-conserved patients received, in addition, a
sequential boost of 16 Gy delivered in 8 fractions overtwo weeks to the initial tumor bed using a direct electron
field. In the experimental group, a dose of 42 Gy was
delivered in 15 fractions over three weeks to the chest
wall in cases of mastectomy, or to the whole breast in
cases of breast-conserving surgery, and to the supraclavi-
cular, infraclavicular and axillary nodes in cases of pN1
status, using the image-guided radiotherapy system
TomoTherapy (TomoTherapy Inc., Madison, WI, USA).
Breast-conserved patients received a simultaneous inte-
grated boost of 9 Gy delivered in 15 fractions over the
three weeks.
Per protocol, radiotherapy had to start within six weeks
of breast surgery, or, in case of adjuvant chemotherapy,
within six weeks after completion of the adjuvant chemo-
therapy. Quality of life, arm mobility and volume, pulmon-
ary function and heart function tests were scheduled prior
to radiotherapy, at one to three months after completion
of radiotherapy, then yearly. The primary endpoint of the
trial was the combined pulmonary and cardiac toxicities as
determined by medical imaging and functional tests during
follow-up versus pre-treatment evaluation. The secondary
endpoint was locoregional recurrence. Formal compari-
sons of the endpoints and quality of life between treatment
groups are ongoing but are not the purpose of the present
study. The focus of the study is scapula alata and the phys-
ical therapy assessment made prior to radiotherapy and at
the first follow-up one to three months after radiotherapy.
Written informed consent was obtained from the
patients for publication of this report and any accom-
panying images.
Physical therapy assessment
Patient’s subjective arm symptoms, physical shoulder-
arm evaluation, and presence or not of scapula alata
were assessed by a physical therapist after the patient’s
consent to participate in the trial but before radiotherapy
(pre-RT evaluation) and at one to three months after the
last radiotherapy session.
Subjective arm symptoms were recorded as present or
absent. Arm symptoms were considered present when
the patient reported for the operated arm/hand any
symptom of dysesthesia, heaviness, swelling, fatigue,
more effort needed, warmth, burning or pain. Arm
symptoms were considered absent when the patient
reported none of these symptoms.
Shoulder-arm evaluation recorded the following mea-
surements (Figure 1):
– Arm volume, computed from circumferential
measurements using the mean of the frustum sign
and the cylinder model method as detailed in
Appendix 1 of Additional file 1 [12].




Endorotation. Scapular distance. 
Figure 1 Physical measurements. Measured at five locations (marked with a dermographic pencil but not visible in the picture). The tape box
has a push button to maintain the same tension. Abduction: running angle by lateral elevation, measured between the midline of the hemibody
(goniometer’s arm in line with the ipsilateral posterior superior iliac spine), and the midline of the upper arm (goniometer’s arm in line with the
lateral epicondyle of the humerus). Retroflexion: running angle by posterior elevation, measured between the midline of the body (goniometer’s
arm in line downward with the trochanter major), and the midline of the upper arm (goniometer’s arm in line with the lateral epicondyle of the
humerus). Anteflexion: running angle by anterior elevation, measured between the midline of the body (goniometer’s arm in line downward with
the trochanter major), and the midline of the upper arm (goniometer’s arm in line with the lateral epicondyle of the humerus). Endorotation: the
thumb as close as possible to C7. The number of vertebrae between C7 and the vertebra that can be reached with the thumb is marked as
endorotation measurement. Scapular distance: with the patient’s arms held actively at 90° anteflexion, the distance of the scapula inferior angle to
the spine, perpendicularly to the spine, is measured with a tape.
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arm (anteflexion).
– Maximum range of active backward elevation of the
arm (retroflexion).
– Maximal functional endorotation measured by
counting the vertebrae between C7 and the most
cranial vertebra the patient could reach with her
thumb on her back.
– Scapular distance (the lateral scapular slide test),
measured as the distance between the spine and the
angulus inferior of the scapula, with the arms
elevated 90° in the scapular plane [13].
Note that impairment of arm mobility is indicated by
decreased abduction, anteflexion, and/or retroflexion.
However, impairment of endorotation would be marked
by the inability of the hand on the back to reach closer
to the neck, with consequently an increased count of
vertebrae. Likewise, shoulder injury might entail
decreased ability of the scapula to slide toward the spine,
with consequently an increased scapular distance [14,15].
All measurements were made on both arms, ipsilaterally
and contralaterally to the operated side. For the present
study, we took into consideration only measurements
pertaining to the ipsilateral arm.
Scapula alata was assessed through visual observation
of tilting and winging of the scapulae (Figure 2). The ob-
servation was performed with the subject instructed to
stand relaxed and perform active elevation of the arms in
the scapular plane until shoulder height. No differenti-
ation in the amount of elevation was specified. The pa-
tient was observed from dorsal (frontal plane) and lateral
(sagittal plane). Normally, the inferior angle should be
flat against the chest wall [16] and the scapulae should
be 30° internally rotated with respect to the frontal plane
[17]. Scapular positioning was deemed impaired when:
– the inferior angle of the scapula became prominent
dorsally (rotating about the horizontal axis - tilting;
– the entire medial border of the scapula became
prominent dorsally (rotation about the vertical
axis - winging.
If one or both criteria listed above were fulfilled, we
scored scapula alata as 1 (SA present), only if there was a
clear observation of the positioning fault. If none of the
criteria were met, we judged scapula alata as 0 (no SA).
Each position was observed and evaluated once.
Statistical analyses
In order to evaluate shoulder/arm morbidity on a com-
mon scale and to avoid reliance on the contralateral
arm measurements, we computed the outcome of a
shoulder/arm measurement as the percentage changeof the measurement that occurred over time, between
pre-RT assessment (= time T0) and post-RT assessment
(= time T1) of the ipsilateral arm. That is, for volume,
the percent change of volume was computed as: 100 x
(volume of arm at T1 – volume of arm at T0)/volume
of arm at T0. Likewise, for abduction, the percentage
change of abduction was computed as 100 x (abduc-
tion at T1 – abduction at T0)/abduction at T0, and so on
for retroflexion, anteflexion, endorotation, and scapular
distance. The percentage changes of the measurements
were analyzed as continuous variables, and were also ana-
lyzed as categorized variables. Categorization used cutoffs
for limb edema and for motion impairment derived from
the Common Terminology Criteria for Adverse Events
version 4.0 (CTCAE 4.03) [18]. For arm swelling, the cut-
offs applied were Grade 0 = less than 5%, Grade 1 = 5% to
less than 10%, Grade 2 = 10% to less than 30%, and Grade
3 = 30% or more increase of arm volume, where percent-
age increases are computed as defined above, in order to
avoid reliance on the contralateral limb [19]. For loss of
range of motion, the cutoffs applied were Grade 0 = 5% or
less, Grade 1 =more than 5% to 25%, Grade 2 =more
than 25% to 50%, and Grade 3 =more than 50% loss of
motion. CTCAE 4.03 does not specify a lower bound in
the definition of Grade 1 toxicity. We implemented a
lower bound of 5% in order to take into account the nor-
mal variability of range of motion [20-25].
Fisher’s exact test was used for the analysis of data cate-
gorized in contingency tables [26]. Cochran-Armitage’s
trend test was used for ordinal tables [27] (pp 504-509).
Odds ratio relating SA with patients’ characteristics were
computed by conditional maximum likelihood. Logistic
regression was used to evaluate the multivariate associ-
ation of patients’ characteristics with SA. Significance
testing of continuous measurements used Student’s t-test.
P-values from one-sided or two-sided tests are indi-
cated as 1P or 2P, respectively. The overall assessment
of multiple outcomes used Brown’s method to combine
non-independent tests of significance [28].
All statistical computations used R version 2.14.1 [29].
Missing data were imputed using the method of
multivariate imputation by chained equations from package
‘mice’ [30]. Variables used for imputation are listed in
Appendix 2 of Additional file 1. Fisher’s exact test and odds
ratios were computed using the function ‘fisher.test’.
Ordinal test of proportions used the function ‘prop.trend.
test’. Logistic regression used the function ‘glm’ [31].
Brown’s method for combining non-independent tests of
significance [28] was computed using an in-house R script
(Additional file 2).
Results
The TomoBreast trial was opened to accrual on 1 May
2007, and closed accrual on 31 August 2011. A total of
A.Pat1 PreRT B.Pat1 PreRT
C.Pat2 PreRT D.Pat2 PreRT
E.Pat2 PostRT F.Pat2 PostRT
G.Pat3 PreRT H.Pat3 PreRT
Figure 2 Scapular winging. Scapula alata assessed in TomoBreast patients. (A) Patient 1 pre-RT arms relaxed, (B) Patient 1 pre-RT arms elevated,
(C) Patient 2 pre-RT arms relaxed, (D) Patient 2 pre-RT arms elevated, (E) Patient 2 post-RT arms relaxed, (F) Patient 2 post-RT arms elevated,
(G) Patient 3 pre-RT arms relaxed and (H) Patient 3 pre-RT arms elevated.
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Table 1 Patients’ characteristics
Characteristic
(mean)




n = 106 n=13
n (row%) n (row%)
Age (mean 56.6) 4.8 0.009
<50 years 34 26 (76.5) 8 (23.5)




<70 kg 70 59 (84.3) 11 (15.7)
>= 70 49 47 (95.9) 2 (4.1)
Height (mean 1.62) 1.7 0.346
<1.60 m 33 28 (84.8) 5 (15.2)




<25 kg/m2 61 50 (82) 11 (18)




No 86 76 (88.4) 10 (11.6)
Yes 22 19 (86.4) 3 (13.6)
Missing 11 11 (100) 0 (0)
Side of surgery is
dominant arm
0.5 0.378
No 63 58 (92.1) 5 (7.9)
Yes 55 47 (85.5) 8 (14.5)
Missing 1 1 (100) 0 (0)
Breast surgery 2.3 0.221
Mastectomy 43 36 (83.7) 7 (16.3)
Breast-conserving 76 70 (92.1) 6 (7.9)
Axillary surgery 6.1 0.005
Axillary dissection 47 37 (78.7) 10 (21.3)




<10 77 72 (93.5) 5 (6.5)
>= 10 42 34 (81) 8 (19)
Chemotherapy 0.4 0.257
No 64 59 (92.2) 5 (7.8)
Yes 55 47 (85.5) 8 (14.5)
Type of RT 0.5 0.387
Short-course IGRT 61 56 (91.8) 5 (8.2)
Conventional RT 58 50 (86.2) 8 (13.8)
RT regional nodes 0.6 0.108
No 82 76 (92.7) 6 (7.3)
Yes 37 30 (81.1) 7 (18.9)
2P, two-sided P-value from Fisher’s exact test; IGRT, image-guided
radiotherapy; RT, radiotherapy.
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ineligible, one presented bilateral breast cancer, the other
retracted participation. Of the 121 eligible patients, two
had no follow-up physical examination, leaving 119
patients available for analysis. Missing data were pre-RT
arms symptoms not recorded in eleven patients, and the
side of the dominant arm not recorded in one patient
(Table 1). One patient was in a wheelchair at the pre-RT
assessment, so retroflexion of both arms could not be
measured and were assigned as missing. One patient had
long-standing contralateral arm paralysis, but this did
not affect the present analyses, which did not rely on
contralateral arm measurements.
The mean time between breast surgery and the pre-RT
physical therapy assessment was 50.5 days (median 38,
range 17 to 204). The mean time between pre-RT assess-
ment and start of radiotherapy was 6.2 days (median 6,
range 15 to 27), that is, 6 patients had their “pre-RT” as-
sessment delayed to 1, 4, 5, 6, 8, and 15 days after the
start of radiotherapy. The mean RT duration was 33 days
(median 32, range 18 to 54). The mean time between
pre-RT assessment and post-RT assessment was
108.6 days (median 105, range 68 to 235).
The incidence of SA observed at a mean of 50.5 days
after surgery but prior to radiotherapy was 10.9% (= 13
of 119). At 1 to 3 months after finishing radiotherapy,
which corresponded to a mean time interval of 108.6 days
after the pre-RT assessment, SA resolved in 61.5% (= 8
of 13) patients, but persisted in the other 38.5% (= 5 of
13). Moreover, SA appeared after radiotherapy in 1 pa-
tient who had no SA at the pre-RT assessment, bringing
the post-RT incidence to 5.0% (= 5 + 1 of 119).
Patients’ characteristics are summarized in Table 1.
The majority of patients were older than 50 years, with a
mean age of 56.6 years (range 32 to 81). Mean pre-RT
weight was 68.4 kg (range 42 to 150) and mean height
was 1.62 m (range 1.40 to 1.83), resulting in a mean pre-
RT BMI of 25.9 kg/m2 (range 17.3 to 51.3). The mean
number of lymph nodes examined was 8.2 (range 1 to
35). Taking into account the type of axillary surgery, the
mean and range of number of examined nodes were 2.9
(1 to 7) by sentinel node biopsy, and 16.3 (3 to 35) by ax-
illary dissection.
Factors significantly associated with pre-RT SA were
age, body mass index, and axillary dissection (Table 1):
pre-RT SA was observed in about 1 of 4 patients
younger than 50 years old, in 1 of 5 patients with body
mass index less than 25 kg/m2, and in 1 of 5 patients
who had axillary dissection. The univariate odds ratios
were 4.8, 6.1, and 6.1, respectively. Younger age, lower
body mass index, and axillary dissection remained sig-
nificant factors associated with pre-RT SA in a trimmed
multivariate logistic regression (Table 2), as well as in a
full model (Appendix 4 in Additional file 1). Figure 3
Table 2 Multivariate association of patients’ characteristics with pre-radiotherapy scapula alata
Odds Ratio 95% confidence interval 2P
Axillary lymph node dissection vs. sentinel nodes biopsy 10.62 (2.6–57.0) 0.002
Body mass index <25 vs. >= 25 10.53 (2.3–78.7) 0.007
Age at surgery <50 years old vs. >= 50 4.25 (1.1–17.9) 0.037
2P, two-sided P-value from logisitic regression.
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to post-RT, for each of the shoulder/arm assessments,
according to patients’ pre-RT SA status. The top row
shows outcomes of patient without pre-RT SA, and the
bottom row shows the outcomes of patients who pre-
sented with pre-RT SA. The histograms show that
patients with pre-RT SA presented an increase in arm
volume (distribution of bars and density curve shift to
>0%), a decrease of abduction (shift to <0%), a decrease
of retroflexion (shift to <0%), a small decrease of ante-
flexion (secondary peak <0%), a decrease of endorota-
tion (shift to <0%), and both increase and decrease of
scapular distance (shift to both negative and positive
change).
Table 3 summarizes the percentage changes of the
measurements that were observed after RT and the cor-
responding significance tests, according to pre-RT SA
status. Measurements were complete, except retroflexion
which was imputed in one patient. There were no not-
able changes of the measurements between pre-RT and
post-RT assessments among the non-SA patients, except
scapular distance that increased by 3.1%. The overall
combined test for non-SA patients was not significant,
one-sided P= 0.148. Among SA patients, arm volume
significantly increased by 4.1%, 1P= 0.036, and arm ab-
duction decreased significantly by 8.6%, 1P= 0.046















































































Figure 3 Histograms of shoulder/arm percent changes, according to s
alata status pre-radiotherapy, Y-axis, relative frequency density.retroflexion of 7.0% and increased scapular distance of
19.5% among SA patients. The overall combined test for
SA patients reached significance, 1P= 0.043. The per-
centage changes are shown as categorized toxicity grades
in Table 4 and Figure 4. Whereas the previous Table 3
evaluated how physical measurements changed over time
according to SA status, Table 4 directly compares the
changes between the two SA groups of patients. Patients
with pre-RT SA presented with more Grade 1 to 3 tox-
icity by arm volume, abduction, retroflexion, and scapu-
lar distance, but comparable endorotation toxicity, and
less anteflexion toxicity. Figure 4 displays that patients
with pre-RT SA experienced comparatively more fre-
quent toxicities than patients without pre-RT SA, in four
out of the six physical assessments (fewer Grade 0,
represented as light blue bars), and more frequently with
higher grades of toxicities (more Grade 2 and 3, repre-
sented as red and black bars).
Discussion
The present study found a non-negligible incidence of
SA in 13 of 119 patients (10.9%) at a mean time interval
of 7 weeks (50.5 days) after surgery. Recovery was
observed in 8 of the 13 patients 16 weeks (108.6 days)
later, in keeping with other observations. Lotze et al.
reported that serratus anterior palsy occurred in 30% of
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capula alata status. Curves, continuous density estimates; SA, scapula
Table 3 Ipsilateral shoulder-arm measurements before and after radiotherapy (RT), according to scapula alata status











Volume 1689 (ml) +0.7% 0.152 1554 (ml) +4.1% 0.036
Abduction 121 (degrees) +2.3% 0.818 126 (degrees) –8.6% 0.046
Retroflexion* 50 (degrees) –2.5% 0.086 52 (degrees) –7.0% 0.119
Anteflexion 141 (degrees) +2.8% 0.987 136 (degrees) +3.7% 0.871
Endorotation 7 (n vertebrae) +1.3% 0.304 8 (n vertebrae) +0.5% 0.485
Scapular distance 14 (cm) +3.1% 0.037 11 (cm) +19.5% 0.077
Brown's combined test – – 0.148 – – 0.043
*Retroflexion was imputed in one patient. 1P, one-sided P-value from paired Student’s t-test.
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6 months after the intervention [6]. de Oliveira et al.
reported that the post-operative incidence of SA was
73.3% immediately after axillary lymphadenectomy,
65.6% after 90 days and 27.7% at the end of follow-up
(416 days) [9]. Meininger et al. reported that most cases
of SA resolved within six to nine months [32]. In Martin
and Fish’s review, most cases of isolated serratus anterior
palsy resolved with conservative treatment within one to
twenty-four months [2].
In line with other authors who compared the SA
incidence according to ALND or SNB [4], ALND was
one of the most significant risk factor of SA, with SA
observed in 10 of 47 (21.3%) ALND patients, as com-
pared with 3 of 72 (4.2%) SNB patients (Table 1). Even
though the long thoracic nerve is identified and pre-
served during axillary dissection [33-36], a higher risk of
damage than with sentinel nodes biopsy can be expected
to occur. We note that using a logistic regression model
that includes age, body mass index, and ALND (Table 2),
the expected risk of SA would range from 0.4% in the
lowest risk group (older overweight patients treated with
SNB), to 63% in the highest risk group (younger leaner
patients treated with ALND). This suggests that the
variability of SA incidence might be explained, at least in
part, by the heterogeneity of populations.
The relationship of lean body weight with increased
risk of SA, or conversely the apparent decreased risk of
SA with large body weight, is intriguing. We searched
the literature on scapular winging of all causes, but
found no direct mention of any relationship between SA
and weight or BMI. However, in 25 papers that we found
reporting pictures of patients, counting multiple
photographs of the same patient as only one to avoid
duplicated counting, we identified 47 distinct cases: all
were lean or average body frame patients, there was no
photograph of any overweight case [1,2,10,32,37-57]. The
published cases lend support to our observation that
weight is inversely related with SA. A tentative explanationis that lean patients might be more at risk of nerve and
muscle injury than overweight patients, as there would be
less axillary room and fat to move around to spare the long
thoracic nerve, and a higher risk of indirect damage by
vascular disruption, scarring, or compression against the
chest wall. An alternative plausible explanation is that SA is
more readily overlooked in overweight patients, in whom
positional changes of the scapula would be masked by the
overlying adipose tissues. If that is the case, then the true
incidence of SA might have been underestimated. We note
that in our one patient who had onset of post-RT SA, we
found no hint to attribute SA to surgery or to radiotherapy.
She was 45 years old, had breast-conserving surgery,
sentinel nodes biopsy without ALND, irradiation to the
breast without regional node irradiation. But, between the
pre-RT assessment and the post-RT assessment, she
experienced a weight loss of 10 kg, from a pre-RT weight of
67 kg, her BMI dropped from 24.9 kg/m2 before
radiotherapy, to 21.2 kg/m2 thereafter. Incidentally, we
found only one case report of SA occurring early after
radiotherapy [40]. Our patient would represent the second
case so reported to the literature.
Our analyses found that younger age was a significant
risk factor for SA. The literature provides scarce and
contradictory data regarding age and the incidence of SA
after breast cancer surgery. In Pereira et al.’s series of
patients, the mean age was 60.3 years, but the
relationship of SA with age was not investigated [58].
Contrarily to our observation, Ribeiro et al. reported in
an abstract that age >60 years by logistic regression was
associated with an increased SA relative risk of 3.14 [59].
Crude figures were not provided, hence the consistency
of Ribeiro et al.’s logistic regression with data could not
be ascertained, whereas our logistic regression was
concordant with our raw data. de Oliveira et al. found
no significant association of SA with age or any other
characteristic [9]. However, in de Oliveira et al.’s report,
at mean follow-up of 416 days, the relative risk of SA for
age >65 vs. age <65 years was 0.53 (95% CI 0.26-1.07),
Table 4 Ipsilateral shoulder/arm toxicity according to pre-
radiotherapy scapula alata status (SA pre-RT)
All SA pre-RT absent SA pre-RT present 2P
n n (col%) n (col%)
Volume 0.013
Grade 0 92 85 (80.2) 7 (53.8)
Grade 1 14 12 (11.3) 2 (15.4)
Grade 2 13 9 (8.5) 4 (30.8)
Grade 3 0 0 (0) 0 (0)
Abduction 0.228
Grade 0 69 63 (59.4) 6 (46.2)
Grade 1 35 31 (29.2) 4 (30.8)
Grade 2 15 12 (11.3) 3 (23.1)
Grade 3 0 0 (0) 0 (0)
Retroflexion 0.312
Grade 0 58 52 (49.1) 6 (46.2)
Grade 1 52 48 (45.3) 4 (30.8)
Grade 2 8 5 (4.7) 3 (23.1)
Grade 3 1 1 (0.9) 0 (0)
Anteflexion 0.463
Grade 0 91 80 (75.5) 11 (84.6)
Grade 1 28 26 (24.5) 2 (15.4)
Grade 2 0 0 (0) 0 (0)
Grade 3 0 0 (0) 0 (0)
Endorotation 0.668
Grade 0 79 69 (65.1) 10 (76.9)
Grade 1 28 26 (24.5) 2 (15.4)
Grade 2 8 8 (7.5) 0 (0)




Grade 0 73 68 (64.2) 5 (38.5)
Grade 1 36 32 (30.2) 4 (30.8)
Grade 2 5 4 (3.8) 1 (7.7)
Grade 3 5 2 (1.9) 3 (23.1)
2P, two-sided P-value from ordinal trend test.
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obvious explanation why young age would be a risk
factor. We can only remark that outside the context of
breast cancer, reports of conditions related to scapular
winging appear with regard to young and active patients
[49,51]. The largest case series of serratus anterior
paralysis reported for 197 patients with a mean age of
31.6 years [60]. The literature that we browsed in the
discussion about weight was also striking by the
preponderance of young patients close to that age.
Regarding the relationship of SA with shoulder/arm
morbidity, we encountered two particular issues. One
issue is contralateral shoulder/arm morbidity, which werecently found was correlated with ipsilateral morbidity
[19]. The other issue was the different measurement
scales using different units. We implemented the
percentage change of measurement that occurred over
time on the ipsilateral limb, therefore avoiding the need
to rely on measurements of the contralateral limb,
providing the same scale to the measurements, and
further allowing links with the common terminology
criteria for adverse events [18].
Some discrepancies could be noted in the relationship
between SA and shoulder/arm morbidities, such as
improved anteflexion and improved endorotation, albeit
non-significant (Table 3). Yet, the overall results indicate
that SA might be an important early indicator of higher
risk of shoulder/arm morbidity. As shown in Table 3 and
Figure 3, patients with SA prior to RT (that is, on average
seven weeks after surgery) presented more frequently with
altered shoulder/arm assessment. Interestingly, the Brown’s
combined test which takes into account the correlation
between outcomes was significant. This matches the clinical
interpretation of shoulder/arm assessments: while each
measurement considered separately might show only small
alterations, taken all together the measurements might
indicate more substantial risk of morbidity, notably
lymphedema or loss of motion (Table 4 and Figure 4).
We are aware of the limitations of the present study.
No physical assessment was done prior to surgery,
precluding the possibility of analyzing the impact of pre-
existing morbidities. The number of patients was small,
which did not allow comprehensive analyses, modeling
gave results difficult to interpret (Appendix 6 in
Additional file 1), therefore limiting the scope of the
present study to a descriptive stance. The follow-up was
short. Though SA appeared as a predictor of early
shoulder/arm toxicities, its value as a predictor of long-term
toxicities remains unknown. We did not assess compliance
of patients with preventive physical therapy. We did not
assess the reproducibility of measurements. It has been
argued there is no consistent evidence that any examination
procedure used in shoulder assessments has acceptable
levels of reliability [61]. Contrariwise, assessment of scapular
positioning and winging has been reported to be reliable
[62,63]. In order to evaluate inter-observer variability, the
present study could have benefited from repeated
assessment by different observers. This was not built into
the trial’s design in view of the trial’s time constraints and
examinations that patients underwent. Until the present
study, we had no a priori reason to give precedence to SA
assessment. The study could also have benefited from
advanced scapular motion tracking and from electromyo-
graphic confirmation of serratus palsy [64]. But, for the
same reason that multi-observer assessments were not




















































Figure 4 Toxicity grades according to scapula alata status. SA, scapula alata pre-radiotherapy status, 0 = absent, 1 = present.
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http://www.wjso.com/content/10/1/86The strengths of the study are its prospective nature, the
patients were consistently evaluated clinically by the same
team within the same institution throughout the study dur-
ation. Good internal consistency of measurements done by
the same observer could be expected [13,62]. The physical
therapy assessment was blinded to patients’ randomization
allocation. Furthermore, the assessors were not involved in
the physical therapeutic management of the patients. We
have mentioned as a limitation that compliance was not
assessed. Yet, this concurred to strengthen the study against
bias that could have resulted from knowing patients’
treatments. We believe that the results are robust and
warrant further investigations.Conclusion
In this study, we analyzed the change of SA incidence
after post-surgery radiotherapy for breast cancer and the
physical functioning factors related with SA. The results
confirm the previously known association of SA with
ALND. We found an inverse association of SA with age
and body weight, not previously reported in the
literature, the latter suggesting that SA might have been
underestimated. Post-surgery SA appeared to recover in
a majority of patients at 15 weeks of follow-up. However,
we also found that despite the recovery, SA portended
an increased risk of loss of shoulder-arm mobility.
We argue that scapular winging is not an innocuous
sign, that it should be actively evaluated in order toidentify patients who might be most at need of close
physical therapy management.Additional files
Additional file 1: Appendix 1. Computing volume from circumference
measurements for TomoBreast patients: Appendix 2. A list of variables
used for imputation of missing data; Appendix 3. The relationships
between scapula alata and characteristics; Appendix 4. Logistic regression,
all variables without selection; Appendix 5. Figure of shoulder/arm
percentage changes from pre- to post-radiotherapy, according to scapula
alata status; Appendix 6: Post-radiotherapy outcomes (percentage change
of shoulder/arm measurement between pre- and post-RT) and linear
predictors.
Additional file 2: File format PDF. Brown.combined.Pvalues.Abbreviations
ALND: Axillary lymph node dissection; IGRT: Image-guided radiotherapy;
RT: Radiotherapy; SA: Scapula alata; SNB: Sentinel nodes biopsy.Competing interests
The authors declare that they have no competing interests. The first author
(NA) is a bursary of the IWT, Belgian Agency for Innovation by Science and
Technology, http://www.iwt.be/. The trial was funded by grant SCIE2006-30
from the Stichting tegen Kanker, Belgian Foundation against Cancer, http://
www.kanker.be/. The Radiotherapy Department of the University Hospital,
Brussels had a research agreement with TomoTherapy Inc. (Madison, WI,
USA) and Orfit Industries (Wijnegem, Belgium). None of the funding agencies
were involved in the study design; in the collection, analysis and
interpretation of data; in the writing of the manuscript; or in the decision to
submit the manuscript for publication.
Adriaenssens et al. World Journal of Surgical Oncology 2012, 10:86 Page 11 of 12
http://www.wjso.com/content/10/1/86Acknowledgements
We gratefully acknowledge Eva Swinnen who helped with the study design
and with the physical evaluation of the first study patients. We are grateful to
all patients who participated in the trial.
Author details
1Breast Clinic, Oncologic Surgery, Universitair Ziekenhuis Brussel, Laarbeeklaan
101, 1090 Brussels, Belgium. 2Department of Radiotherapy, Oncology Centre,
Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium.
3Physical Therapy Department, Vrije Universiteit Brussel, Laarbeeklaan 103,
1090 Brussels, Belgium. 4Radiation Oncology, Geneva University Hospitals,
Rue Gabrielle-Perret-Gentil 4, 1211 Geneva 14, Switzerland.
Authors’ contributions
NA was the trial's co-investigator, designed the study, collected and analysed
the data, and drafted the manuscript. MDR was the trial's director, edited and
critically reviewed the manuscript. PL, MVo, and GS edited and critically
reviewed the manuscript. HVP was the trial's co-investigator, collected the
data, and drafted the manuscript. MVa collected the data, ensured patients’
follow-up, and edited the manuscript. GM collected data, evaluated patients,
edited and critically reviewed the manuscript. HV did the data management,
and drafted the manuscript. JL contributed to patients’ follow-up, edited and
reviewed the manuscript. SP contributed to data collection and to
manuscript writing. VVH was the trial's principal investigator, provided the
study concept, analysed the data analysis, and wrote the manuscript. All
authors read and approved the final manuscript.
Received: 15 December 2011 Accepted: 16 May 2012
Published: 16 May 2012
References
1. Vanderstraeten J: Scapula alata. Rev Med Gen 2010, 269:32–33.
2. Martin RM, Fish DE: Scapular winging: anatomical review, diagnosis, and
treatments. Curr Rev Musculoskelet Med 2008, 1:1–11.
3. Kauppila LI, Vastamaki M: Iatrogenic serratus anterior paralysis. Long-term
outcome in 26 patients. Chest 1996, 109:31–34.
4. Paim CR, de Paula Lima ED, Fu MR, de Paula LA, Cassali GD: Post
lymphadenectomy complications and quality of life among breast
cancer patients in Brazil. Cancer Nurs 2008, 31:302–309.
5. Velpeau AALM: Traite d’anatomie chirurgicale ou anatomie des regions,
consideree dans ses rapports avec la chirurgie. Paris, France: Crevot; 1825.
6. Lotze MT, Duncan MA, Gerber LH, Woltering EA, Rosenberg SA: Early versus
delayed shoulder motion following axillary dissection: a randomized
prospective study. Ann Surg 1981, 193:288–295.
7. Roses DF, Brooks AD, Harris MN, Shapiro RL, Mitnick J: Complications of
level I and II axillary dissection in the treatment of carcinoma of the
breast. Ann Surg 1999, 230:194–201.
8. Saied GM, Kamel RM, Dessouki NR: The effect of mastectomy and
radiotherapy for breast carcinoma on soft tissues of the shoulder and its
joint mobility among Egyptian patients. Tanzan Health Res Bull 2007,
9:121–125.
9. de Oliveira JF, Bezerra T, Ribeiro ACP, Dias RA, Abrahao F, Silva JG,
Bergmann A: Incidence and risk factors of winged scapula after axillary
lymph node dissection in breast cancer surgery. Appl Cancer Res 2009,
29:69–73.
10. de Sousa Mastrella A, Freitas-Junior R, Paulinelli RR, Soares LR: Escápula
alada pós-linfadenectomia no tratamento do câncer de mama. Rev Bras
Cancerologia 2009, 55:397–404.
11. Efron B: Forcing a sequential experiment to be balanced. Biometrika 1971,
58:403–417.
12. Karges JR, Mark BE, Stikeleather SJ, Worrell TW: Concurrent validity of
upper-extremity volume estimates: comparison of calculated volume
derived from girth measurements and water displacement volume.
Phys Ther 2003, 83:134–145.
13. Nijs J, Roussel N, Vermeulen K, Souvereyns G: Scapular positioning in
patients with shoulder pain: a study examining the reliability and clinical
importance of 3 clinical tests. Arch Phys Med Rehabil 2005, 86:1349–1355.
14. Kibler WB: Role of the scapula in the overhead throwing motion.
Contemp Orthop 1991, 22:525–532.
15. Kibler WB: The role of the scapula in athletic shoulder function.
Am J Sports Med 1998, 26:325–337.16. Mottram SL: Dynamic stability of the scapula. Man Ther 1997, 2:123–131.
17. de Groot JH: The scapulo-humeral rhythm: effects of 2-D roentgen
projection. Clin Biomech (Bristol, Avon) 1999, 14:63–68.
18. National Cancer Institute: Common Terminology Criteria for Adverse Events
(CTCAE). Version 4.0. NIH Publication No. 09-5410.: ; 2010. Revised June 2010.
19. Adriaenssens N, Vinh-Hung V, Miedema G, Versmessen H, Lamote J,
Vanhoeij M, Lievens P, Van Parijs H, Storme G, Voordeckers M: Early
contralateral shoulder-arm morbidity in breast cancer patients enrolled
in a randomized trial of post-surgery radiation therapy. Breast Cancer
2012, in press.
20. Riddle DL, Rothstein JM, Lamb RL: Goniometric reliability in a clinical
setting. Shoulder measurements. Phys Ther 1987, 67:668–673.
21. Barnes CJ, Van Steyn SJ, Fischer RA: The effects of age, sex, and shoulder
dominance on range of motion of the shoulder. J Shoulder Elbow Surg
2001, 10:242–246.
22. Conte AL, Marques AP, Casarotto RA, Amado-Joao SM: Handedness
influences passive shoulder range of motion in nonathlete adult women.
J Manipulative Physiol Ther 2009, 32:149–153.
23. Roy JS, MacDermid JC, Boyd KU, Faber KJ, Drosdowech D, Athwal GS:
Rotational strength, range of motion, and function in people with
unaffected shoulders from various stages of life. Sports Med Arthrosc
Rehabil Ther Technol 2009, 1:4.
24. Mullaney MJ, McHugh MP, Johnson CP, Tyler TF: Reliability of shoulder
range of motion comparing a goniometer to a digital level. Physiother
Theory Pract 2010, 26:327–333.
25. Van Hoof T, Vangestel C, Shacklock M, Kerckaert I, D’Herde K: Asymmetry
of the ULNT1 elbow extension range-of-motion in a healthy population:
Consequences for clinical practice and research. Phys Ther Sport 2012,
in press.
26. Agresti A: Categorical data analysis. 2nd edition. Hoboken NJ: Wiley; 2002.
27. Armitage P, Berry G, Matthews JNS: Statistical Methods in Medical Research.
Malden, MA: Blackwell Science; 2002. Reprinted 2007. ISBN Fourth.
28. Brown MB: A method for combining non-independent, one-sided tests of
significance. Biometrics 1975, 31:987–992.
29. R Development Core Team: R: A language and environment for statistical
computing. R Foundation for Statistical Computing: Vienna, Austria;
[http://www.R-project.org/]. ISBN 3-900051-07-0.
30. van Buuren S: Multiple imputation of discrete and continuous data by
fully conditional specification. Stat Methods Med Res 2007, 16:219–242.
31. Venables WN, Ripley BD: Modern Applied Statistics with S. 4th edition. New
York: Springer-Verlag; 2002.
32. Meininger AK, Figuerres BF, Goldberg BA: Scapular winging: an update.
J Am Acad Orthop Surg 2011, 19:453–462.
33. Auchincloss H: Significance of location and number of axillary metastases
in carcinoma of the breast: a justification for a conservative operation.
Ann Surg 1963, 158:37–46.
34. Petrek JA, Blackwood MM: Axillary dissection: current practice and
technique. Curr Probl Surg 1995, 32:257–323.
35. Martin JK: Axillary dissection. Oper Tech Gen Surg 2000, 2:152–160.
36. Mostafa A, Mokbel K, Engledow A, Leris AC, Choy C, Wells C, Carpenter R: Is
dissection of the internerve tissue during axillary lymphadenectomy for
breast cancer necessary? Eur J Surg Oncol 2000, 26:153–154.
37. Overpeck DO, Ghormley RK: Paralysis of the serratus magnus muscle,
caused by lesions of the long thoracic nerve. JAMA 1940, 114:1994–1996.
38. Ilfeld FW, Holder HG: Winged scapula: case occurring in soldier from
knapsack. JAMA 1942, 120:448–449.
39. Duncan MA, Lotze MT, Gerber LH, Rosenberg SA: Incidence, recovery, and
management of serratus anterior muscle palsy after axillary node
dissection. Phys Ther 1983, 63:1243–1247.
40. Pugliese GN, Green RF, Antonacci A: Radiation-induced long thoracic
nerve palsy. Cancer 1987, 60:1247–1248.
41. Post M: Pectoralis major transfer for winging of the scapula. J Shoulder
Elbow Surg 1995, 4:1–9.
42. Watson CJ, Schenkman M: Physical therapy management of isolated
serratus anterior muscle paralysis. Phys Ther 1995, 75:194–202.
43. Kibler WB, Uhl TL, Maddux JW, Brooks PV, Zeller B, McMullen J: Qualitative
clinical evaluation of scapular dysfunction: a reliability study. J Shoulder
Elbow Surg 2002, 11:550–556.
44. Wiater JM, Flatow EL: Long thoracic nerve injury. Clin Orthop Relat Res
1999, 368:17–27.
45. Dumontier C, Soubeyran M, Lascar T, Laulan J: Compression du nerf
thoracicus longus (Nerf de Charles-Bell). Chir Main 2004, 23:S63–S76.
Adriaenssens et al. World Journal of Surgical Oncology 2012, 10:86 Page 12 of 12
http://www.wjso.com/content/10/1/8646. Sherman SC, O’Connor M: An unusual cause of shoulder pain: Winged
scapula. J Emerg Med 2005, 28:329–331.
47. Lee SG, Kim JH, Lee SY, Choi IS, Moon ES: Winged scapula caused by
rhomboideus and trapezius muscles rupture associated with repetitive
minor trauma: a case report. J Korean Med Sci 2006, 21:581–584.
48. Vinson EN: Clinical images: scapular winging. Arthritis Rheum 2006,
54:4027.
49. Daubinet G, Graveleau N, Rousseau D: L’epaule du sportif. The athletes
shoulder. Rev Rhum 2007, 74:581–586.
50. Nath RK, Melcher SE: Rapid recovery of serratus anterior muscle function
after microneurolysis of long thoracic nerve injury. J Brachial Plex Peripher
Nerve Inj 2007, 2:4.
51. Noel E: Les syndromes canalaires de l’epaule. Nerve entrapment of the
shoulder. Rev Rhum 2007, 74:339–343.
52. Galano GJ, Bigliani LU, Ahmad CS, Levine WN: Surgical treatment of
winged scapula. Clin Orthop Relat Res 2008, 466:652–660.
53. Aksoy IA, Schrader SL, Ali MS, Borovansky JA, Ross MA: Spinal accessory
neuropathy associated with deep tissue massage: a case report. Arch
Phys Med Rehabil 2009, 90:1969–1972.
54. Cerqueira WA, Barbosa LA, Bergmann A: Proposta de conduta
fisioterapêutica para o atendimento ambulatorial nas pacientes com
escápula alada após linfadenectomia axilar. Rev Bras Cancerologia 2009,
55:115–120.
55. McClure P, Tate AR, Kareha S, Irwin D, Zlupko E: A clinical method for
identifying scapular dyskinesis, part 1: reliability. J Athl Train 2009, 44:160–164.
56. Sivan M, Hassan A: Images in emergency medicine. Winged scapula as
the presenting symptom of Guillain-Barre syndrome. Emerg Med J 2009,
26:790.
57. Blum A, Lecocq S, Louis M, Wassel J, Moisei A, Teixeira P: The nerves
around the shoulder. Eur J Radiol 2011, [epub ahead of print].
58. Pereira TB, Bergmann A, Ribeiro AC, Da Silva JG, Dias R, Ribeiro MJ, Thuler LC:
Myoeletric activity pattern of scapular muscles after axillary
lymphadenectomy in breast cancer. Rev Bras Ginecol Obstet 2009, 31:224–229.
59. Ribeiro A, Bergmann A, Bezerra T, Silva M, Silva J, Ribeiro M, Dias R:
Incidência de escápula alada no pós-operatório de linfadenectomia axilar
[abstract]. Rev Bras Cancerologia 2007, 53:491.
60. Vastamaki M, Kauppila LI: Etiologic factors in isolated paralysis of the
serratus anterior muscle: a report of 197 cases. J Shoulder Elbow Surg
1993, 2:240–243.
61. May S, Chance-Larsen K, Littlewood C, Lomas D, Saad M: Reliability of
physical examination tests used in the assessment of patients with
shoulder problems: a systematic review. Physiotherapy 2010, 96:179–190.
62. Nijs J, Roussel N, Struyf F, Mottram S, Meeusen R: Clinical assessment of
scapular positioning in patients with shoulder pain: state of the art. J
Manipulative Physiol Ther 2007, 30:69–75.
63. Struyf F, Nijs J, De CK, Giunta M, Mottram S, Meeusen R: Clinical assessment
of scapular positioning in musicians: an intertester reliability study.
J Athl Train 2009, 44:519–526.
64. Struyf F, Nijs J, Horsten S, Mottram S, Truijen S, Meeusen R: Scapular
positioning and motor control in children and adults: a laboratory study
using clinical measures. Man Ther 2011, 16:155–160.
doi:10.1186/1477-7819-10-86
Cite this article as: Adriaenssens et al.: Scapula alata in early breast
cancer patients enrolled in a randomized clinical trial of post-surgery
short-course image-guided radiotherapy. World Journal of Surgical
Oncology 2012 10:86.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
